Experts from Columbia University highlight approvals in CLL, bispecific antibodies in multiple myeloma, and actionable biomarkers in DLBCL.
Hua-Jay J Cherng, MD
Advertisement
Articles by Hua-Jay J Cherng, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
What Does the Future Hold for Bispecific Antibodies in Multiple Myeloma?
2
Supervised Keto Diet/Triplet Chemo Improves Survival in Pancreatic Cancer
3
The Impact of GLP-1–Mediated Weight Loss on Mammographic Density and Radiomic Risk
4
Exploring Upfront Cytoreductive Radiotherapy in Advanced RCC
5